SAN
FRANCISCO, March 13, 2025 /PRNewswire/ -- Vitro, a
global developer, manufacturer and marketer of integral diagnostics
solutions and data integration in Cancer Diagnostics, today
announced that it has appointed Biocare Medical, a global leader in
advanced staining solutions and reagents, as the exclusive
distributor for its new NeoPATH Pro instrument in the United States. The NeoPATH Pro will
officially debut at the 2025 United States and Canadian Academy of
Pathology (USCAP) Annual Meeting in Boston, MA.
The NeoPATH Pro is a high-throughput platform
featuring a 42-slide capacity, supporting advanced
immunohistochemistry (IHC), in situ hybridization (ISH), and
fluorescence in situ hybridization (FISH). The distribution
agreement leverages Biocare Medical's extensive expertise and
established presence in advanced staining solutions, providing U.S.
laboratories with enhanced local support, service, and access to
innovative diagnostic technology.
Luis de Luzuriaga,
CEO of Biocare Medical, stated, "We are pleased that Vitro selected
Biocare Medical as the exclusive distributor of the NeoPATH Pro in
the United States. Our proven
commercial excellence will ensure a successful introduction and
adoption of NeoPATH Pro in the U.S. market, supporting laboratories
in delivering enhanced diagnostic services to patients. This
appointment highlights our reputation for excellence and reinforces
our commitment to bringing cutting-edge diagnostic solutions to
laboratories across the country."
Ferrán Prat, CEO of Vitro, added, "Choosing
Biocare Medical as our exclusive U.S. distribution partner aligns
perfectly with our strategy to introduce NeoPATH Pro effectively to
the market. We look forward to launching at USCAP 2025, confident
in Biocare's capability to deliver exceptional customer service and
support."
About Biocare Medical
Biocare Medical is a globally recognized leader
in advanced staining and reagent solutions for
immunohistochemistry, in situ hybridization, and related diagnostic
disciplines. Committed to innovation and quality, Biocare empowers
pathologists and clinical laboratories worldwide to deliver
accurate diagnoses and improved patient outcomes. For more
information, visit www.biocare.net.
About Vitro
Vitro is a global specialized partner for
integrated solutions in Cancer Diagnostics, with more than 30 years
proven track record – Vitro is committed to deliver diagnostic
excellence for all. With a reputation for innovation, reliability,
and high-throughput capabilities, Vitro supports clinical
laboratories in achieving exceptional diagnostic performance. For
more information, visit www.vitro.bio.
Media Contact:
John Steel
9256038027
391757@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vitro-appoints-biocare-medical-as-exclusive-distributor-in-the-us-for-neopath-pro-instrument-launch-at-uscap-2025-302400588.html
SOURCE Biocare Medical
